News
EQS-News: MorphoSys Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
![AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbEFDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--507b344b1f20eff6a87ec7cc44acfa0f3e7ed125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aevis-logo.png?locale=us)
AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016
EQS-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Changes on the Board of Management
![EQS-News: Evotec launches PanOmics data analysis platform PanHunter at Bio-IT World: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBMUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--5ccaaee20e4dd47dccd2b888e74ce998199f16f5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Evotec_high_res_logo_-28blue_and_grey-29.jpg?locale=us)
EQS-News: Evotec launches PanOmics data analysis platform PanHunter at Bio-IT World
![CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits
First bullet point under More Help for Floridians Eligible for Both Medicare and Medicaid section of release dated October 17, 2022, should read: Healthy Options Allowance provides eligible members
![EQS-News: Evotec and TIAP expand LAB150 BRIDGE partnership to include Amgen: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBMUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--5ccaaee20e4dd47dccd2b888e74ce998199f16f5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Evotec_high_res_logo_-28blue_and_grey-29.jpg?locale=us)
EQS-News: Evotec and TIAP expand LAB150 BRIDGE partnership to include Amgen
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
EQS-News: Biotest AG: Biotest AG opens 14th plasma collection centre in the Czech Republic
![Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot: https://mms.businesswire.com/media/20221011005304/en/1597268/5/WG_Extraction%2B_5x4.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeUU4V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3ae394ff9e342bdd7cd2440f4c367e81aa52a512/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/WG_Extraction-2B_5x4.jpg?locale=us)
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot
Waters Corporation (NYSE:WAT) today introduced Extraction+ Connected Device, a new software-controlled product for the Waters™ Andrew+™ Pipetting Robot that automates the preparation of biological
![Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations: https://mms.businesswire.com/media/20221010005204/en/1596329/5/Mental_health_Humana_Foundation.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNjQ2V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d85ef007cd37cc87d9c5b324c6c614d7cfc7ca19/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Mental_health_Humana_Foundation.jpg?locale=us)
Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, today announced the first grants reflecting its elevated focus on advancing health equity and improving
![Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford: https://mms.businesswire.com/media/20221007005094/en/1595143/5/LiamLeanneWaters.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEU0V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--773197e0eba52d93616f46908e131c3dc5fd156b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LiamLeanneWaters.jpg?locale=us)
Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford
Waters Corporation (NYSE: WAT) today announced a combined investment of up to €6 million with support from IDA Ireland to expand its operations in Drinagh, Wexford to fund research and development
![Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung: https://mms.businesswire.com/media/20221004005387/de/1590800/5/Warriors_Ava_%26_Rebecca_Dexcom_G7%5B1%5D.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOEl6V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7d0d7fdcdba1a4f17174e7d043b5f23377e5cfd6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Warriors_Ava_-26_Rebecca_Dexcom_G7-5B1-5D.jpg?locale=us)
Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung
DexCom, Inc. (Nasdaq: DXCM), der weltweit führende Anbieter von Systemen zur kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, gab heute die Einführung des Dexcom G7 Systems
![Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System: https://mms.businesswire.com/media/20221004005386/en/1590800/5/Warriors_Ava_%26_Rebecca_Dexcom_G7%5B1%5D.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzh5V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--77f92fa3767ef50aa50d559df2baf4df6a1e7df9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Warriors_Ava_-26_Rebecca_Dexcom_G7-5B1-5D.jpg?locale=us)
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now
![ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members: https://mms.businesswire.com/media/20221001005004/en/1589832/5/AEP_Quote_-_George_Renaudin.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTh4V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--af50afc865c5d1aae867daa2878b72b97269490a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AEP_Quote_-_George_Renaudin.jpg?locale=us)
ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members
Humana Inc. (NYSE: HUM) today released details of its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2023 – with a clear focus on benefits and support based on what its
![Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis: https://mms.businesswire.com/media/20220929005711/en/1587282/5/DHR-Powder_6b-Flow-Samples_Overall.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzB0V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--def81a660a02be24ca084ffc7b9406150f476e9d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/DHR-Powder_6b-Flow-Samples_Overall.jpg?locale=us)
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis
Waters Corporation (NYSE:WAT) today introduced new, innovative powder rheology tooling and software for its TA Instruments™ HR Rheometers allowing scientists to make preciseii, repeatable powder
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
EQS-News: MorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatment with Monjuvi® (tafasitamab-cxix) for Patients with R/R DLBCL
![Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital: https://mms.businesswire.com/media/20220927006047/en/1584747/5/AcadiaHealthcareHenryFordHealthGroundbreaking.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeVFyV1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7dcc9344e44567c373b694b6576d84d22c045fce/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AcadiaHealthcareHenryFordHealthGroundbreaking.jpg?locale=us)
Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital
Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, broke ground today on a
![Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility: https://mms.businesswire.com/media/20220926005707/en/1582828/5/DJI_0884_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMFlwV1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ea676f96565930842c46beef2998f5d2758b9c9e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/DJI_0884_-281-29.jpg?locale=us)
Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility
Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, today announced its newly built Precision Chemical Manufacturing Facility in Taunton, Mass. has achieved LEED
EQS-News: Biotest AG: Biotest AG opens 13th plasma collection centre in the Czech Republic
![EQS-News: Just – Evotec Biologics awarded contract from the U.S. Department of Defense under accelerated antibodies program: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBMUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--5ccaaee20e4dd47dccd2b888e74ce998199f16f5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Evotec_high_res_logo_-28blue_and_grey-29.jpg?locale=us)
EQS-News: Just – Evotec Biologics awarded contract from the U.S. Department of Defense under accelerated antibodies program
![DGAP-News: Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBMUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--5ccaaee20e4dd47dccd2b888e74ce998199f16f5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Evotec_high_res_logo_-28blue_and_grey-29.jpg?locale=us)
DGAP-News: Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU)
![AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 millionhttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbEFDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--507b344b1f20eff6a87ec7cc44acfa0f3e7ed125/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aevis-logo.png?locale=us)